Rezolute (RZLT) Change in Account Payables (2011 - 2026)
Rezolute (RZLT) posted Change in Account Payables of -$587000.0 for Q1 2026, down 212.02% sequentially from $524000.0 in Q4 2025, and down 117.5% YoY from $3.4 million in Q1 2025.
Powered by 
Analysis
Rezolute (RZLT) Change in Account Payables (2011 - 2026) Analysis & Trends
Rezolute has reported Change in Account Payables for 13 years, with the latest figure at -$587000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 117.5% year-over-year to -$587000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (down 210.12% YoY) and the FY2025 annual result came in at $1.4 million, up 31.21% from the prior year.
- Change in Account Payables slipped to -$587000.0 in Q1 2026 per RZLT's latest filing, from $524000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.4 million in Q1 2025 and troughed at -$2.8 million in Q1 2022.
- A 5-year average of -$74647.1 and a median of -$22000.0 in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables plunged 3700.0% in 2023, then jumped 3630.53% in 2025.
- Over 5 years, Change in Account Payables stood at $1.7 million in 2022, then plunged by 32.89% to $1.2 million in 2023, then dropped by 14.64% to $991000.0 in 2024, then sank by 47.12% to $524000.0 in 2025, then slumped by 212.02% to -$587000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$587000.0, $524000.0, and -$2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | -587,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -587,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -730,000.00 |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 991,000.00 |
| Sep 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | 853,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | -836,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -559,000.00 |
| Mar 31, 2022 | -2.77 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 555,000.00 |
| Jun 30, 2021 | 223,000.00 |